Roundtables: Connect, collaborate, and conquer

Topics:  

1. Overcoming the barriers to scale-up in cell therapy manufacturing – Hosted by: Elena Matsa, Professor, University College Cork
2. From Bench to Bedside Successfully: ATMPs commercial strategy  long before Phase III– Hosted by: Mayra Battilani Becegato, EMEA Commercial Director, Johnson & Johnson
3. Gene therapy communication strategy: Bridging development, approval and stakeholder engagement beyond KOLs – Hosted by: Micheala Jones, Global Medical Lead, Regeneron
4. Digital Infrastructure & Data Harmonisation: Enablers for CGT Access & Scale – Hosted by: Aneta Tszkiewicz, Director Data Digital, EFPIA
5. Funding strategies for early-stage cell and gene therapy companies. Hosted by: Avencia Snchez-Mejis, CEO & Co-founder, Integra Therapeutics
6. Academic Innovation vs Industry Expectations: How to translate your Preclinical Data - Hosted by: Leila Abbas, Preclinical Lead, Rinri Therapeutics
7. Investor expectations: what do you need for each funding stage?
8. Building the right team – who should be involved at each development stage? Hosted by: Terri Gaskell, CTO, Rinri Therapeutics
9. IP and exclusivity strategies for navigating CGT innovations from conception to commercialization. Hosted by: Jeremiah B. Frueauf Director, Chair of Biotechnology & Chemical Practice Group and Deborah Sterling Director, Sterne Kessler